Merck Stock Surges After Winning Patent Battle Vs. Viatris Over Two Key Drugs
Merck stock jumped Thursday after the company won a patent battle against generic-drug maker Viatris over an ingredient used in diabetes meds.
Merck Stock Surges After Winning Patent Battle Vs. Viatris Over Two Key Drugs
Merck stock jumped Thursday after the company won a patent battle against generic-drug maker Viatris over an ingredient used in diabetes meds.